vs
ACCESS Newswire Inc.（ACCS）与Arcturus Therapeutics Holdings Inc.（ARCT）财务数据对比。点击上方公司名可切换其他公司
Arcturus Therapeutics Holdings Inc.的季度营收约是ACCESS Newswire Inc.的1.2倍（$7.2M vs $5.8M），ACCESS Newswire Inc.同比增速更快（-0.5% vs -68.4%），过去两年ACCESS Newswire Inc.的营收复合增速更高（2.0% vs -56.5%）
ACCESS通讯社是一家新闻通稿分发服务商，总部位于芝加哥，1954年成立，最初通过电传设备为企业向新闻机构电子传输新闻稿，创始人赫伯特·穆舍勒曾在曼哈顿家中运营该业务长达15年，公司几经转手后，于2015年被Cision集团宣布收购。
Arcturus Therapeutics Holdings Inc.是一家专注于RNA药物研发的美国生物科技企业，核心业务覆盖罕见病与传染病领域药物的研发、开发与商业化。该公司自主研发了专属脂质纳米颗粒递送技术，可用于递送小干扰RNA、信使RNA、基因编辑RNA、DNA、反义寡核苷酸、微小RNA等多种核酸药物。
ACCS vs ARCT — 直观对比
营收规模更大
ARCT
是对方的1.2倍
$5.8M
营收增速更快
ACCS
高出67.9%
-68.4%
两年增速更快
ACCS
近两年复合增速
-56.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.8M | $7.2M |
| 净利润 | $-576.0K | — |
| 毛利率 | 77.4% | — |
| 营业利润率 | -13.1% | — |
| 净利率 | -9.9% | — |
| 营收同比 | -0.5% | -68.4% |
| 净利润同比 | 94.4% | 3.1% |
| 每股收益（稀释后） | $-0.16 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACCSARCT
| Q4 25 | $5.8M | $7.2M | ||
| Q3 25 | $5.7M | $17.2M | ||
| Q2 25 | $5.6M | $28.3M | ||
| Q1 25 | $5.5M | $29.4M | ||
| Q4 24 | $5.8M | $22.8M | ||
| Q3 24 | $5.6M | $41.7M | ||
| Q2 24 | $6.0M | $49.9M | ||
| Q1 24 | $5.6M | $38.0M |
净利润ACCSARCT
| Q4 25 | $-576.0K | — | ||
| Q3 25 | $-45.0K | $-13.4M | ||
| Q2 25 | $-475.0K | $-9.2M | ||
| Q1 25 | $5.4M | $-14.1M | ||
| Q4 24 | $-10.2M | $-30.0M | ||
| Q3 24 | $-466.0K | $-6.9M | ||
| Q2 24 | $7.0K | $-17.2M | ||
| Q1 24 | $-139.0K | $-26.8M |
毛利率ACCSARCT
| Q4 25 | 77.4% | — | ||
| Q3 25 | 74.6% | — | ||
| Q2 25 | 76.2% | — | ||
| Q1 25 | 78.0% | — | ||
| Q4 24 | 75.2% | — | ||
| Q3 24 | 75.0% | — | ||
| Q2 24 | 77.2% | — | ||
| Q1 24 | 75.1% | — |
营业利润率ACCSARCT
| Q4 25 | -13.1% | — | ||
| Q3 25 | -3.2% | -96.3% | ||
| Q2 25 | -4.4% | -41.0% | ||
| Q1 25 | -12.4% | -57.3% | ||
| Q4 24 | -245.8% | -146.7% | ||
| Q3 24 | -10.7% | -25.8% | ||
| Q2 24 | -8.8% | -42.4% | ||
| Q1 24 | -15.5% | -80.0% |
净利率ACCSARCT
| Q4 25 | -9.9% | — | ||
| Q3 25 | -0.8% | -78.4% | ||
| Q2 25 | -8.5% | -32.4% | ||
| Q1 25 | 98.4% | -47.9% | ||
| Q4 24 | -175.0% | -131.8% | ||
| Q3 24 | -8.3% | -16.6% | ||
| Q2 24 | 0.1% | -34.5% | ||
| Q1 24 | -2.5% | -70.5% |
每股收益（稀释后）ACCSARCT
| Q4 25 | $-0.16 | — | ||
| Q3 25 | $-0.01 | $-0.49 | ||
| Q2 25 | $-0.12 | $-0.34 | ||
| Q1 25 | $1.40 | $-0.52 | ||
| Q4 24 | $-2.66 | $-1.10 | ||
| Q3 24 | $-0.12 | $-0.26 | ||
| Q2 24 | $0.00 | $-0.64 | ||
| Q1 24 | $-0.04 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $230.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $30.3M | $214.0M |
| 总资产 | $42.0M | $271.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACCSARCT
| Q4 25 | $3.0M | $230.9M | ||
| Q3 25 | $3.3M | $180.4M | ||
| Q2 25 | — | $196.5M | ||
| Q1 25 | — | $216.9M | ||
| Q4 24 | $4.1M | $237.0M | ||
| Q3 24 | — | $237.2M | ||
| Q2 24 | — | $260.3M | ||
| Q1 24 | — | $288.4M |
股东权益ACCSARCT
| Q4 25 | $30.3M | $214.0M | ||
| Q3 25 | $30.8M | $224.6M | ||
| Q2 25 | $30.7M | $231.1M | ||
| Q1 25 | $30.9M | $233.8M | ||
| Q4 24 | $25.2M | $241.0M | ||
| Q3 24 | $35.3M | $261.9M | ||
| Q2 24 | $35.4M | $258.6M | ||
| Q1 24 | $35.2M | $264.0M |
总资产ACCSARCT
| Q4 25 | $42.0M | $271.1M | ||
| Q3 25 | $44.0M | $282.3M | ||
| Q2 25 | $45.6M | $309.3M | ||
| Q1 25 | $47.3M | $331.8M | ||
| Q4 24 | $50.6M | $344.1M | ||
| Q3 24 | $61.7M | $370.7M | ||
| Q2 24 | $62.8M | $388.6M | ||
| Q1 24 | $64.4M | $418.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $258.0K | $-74.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-74.5M |
| 自由现金流率自由现金流/营收 | — | -1035.2% |
| 资本支出强度资本支出/营收 | 0.0% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACCSARCT
| Q4 25 | $258.0K | $-74.3M | ||
| Q3 25 | $-582.0K | $-17.2M | ||
| Q2 25 | $135.0K | $-5.8M | ||
| Q1 25 | $747.0K | $-35.1M | ||
| Q4 24 | $866.0K | $-284.0K | ||
| Q3 24 | $1.5M | $-23.8M | ||
| Q2 24 | $-190.0K | $-30.1M | ||
| Q1 24 | $986.0K | $-5.6M |
自由现金流ACCSARCT
| Q4 25 | — | $-74.5M | ||
| Q3 25 | $-590.0K | $-17.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | $735.0K | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.5M | $-23.8M | ||
| Q2 24 | — | $-30.5M | ||
| Q1 24 | $970.0K | $-5.8M |
自由现金流率ACCSARCT
| Q4 25 | — | -1035.2% | ||
| Q3 25 | -10.3% | -101.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | 13.4% | -120.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 26.5% | -57.2% | ||
| Q2 24 | — | -61.1% | ||
| Q1 24 | 17.4% | -15.3% |
资本支出强度ACCSARCT
| Q4 25 | 0.0% | 3.2% | ||
| Q3 25 | 0.1% | 1.1% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.2% | 0.5% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.1% | 0.2% | ||
| Q2 24 | 0.0% | 0.7% | ||
| Q1 24 | 0.3% | 0.6% |
现金转化率ACCSARCT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -27.14× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACCS
| Cost To Deliver Products | $3.1M | 54% |
| Employee Costs | $1.7M | 29% |
| Other | $1.0M | 17% |
ARCT
暂无分部数据
